Nutrients publishes human clinical study involving AIDP’s Magtein®
AIDP, Inc. is pleased to announce the clinical study publication “A Magtein®, Magnesium L-Threonate, Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults”, in Nutrients on Dec. 8, 2022.
In this double-blind, placebo-controlled study, Magtein®PS, a magnesium L-threonate (Magtein®)- and phosphatidylserine-based formulation additionally containing vitamins C and D, was tested for its cognitive benefits in 109 healthy Chinese adults aged 18–65 years. Subjects were randomly assigned to receive either Magtein®PS or placebo (starch) capsules, at a dose of 2g / day.